Cem Thunstedt
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.
Journal: Cephalalgia : an international journal of headache
Published: June 19, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.
Journal: Neurology
Published: May 27, 2026
Tear fluid Calcitonin gene-related peptide in patients with idiopathic intracranial hypertension headache - a prospective case-control study.
Journal: The journal of headache and pain
Published: May 25, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.
Journal: Neurology
Published: January 28, 2026
Headache knowledge of young neurologists in Germany.
Journal: BMC medical education
Published: September 07, 2025
Headache assessment in the GP practice
Journal: MMW Fortschritte der Medizin
Published: January 17, 2025
Therapeutic Cerebral Fluid Puncture in Patients with Idiopathic Intracranial Hypertension: No Short-Term Effect on Neurocognitive Function.
Journal: Brain sciences
Published: August 11, 2024
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: December 27, 2023
The Impact of Postoperative Tumor Burden on Patients With Brain Metastases.
Journal: Frontiers in oncology
Published: February 05, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026